Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
5 Patents
#12 in Stevenage
#3,213 in United Kingdom
Reviral Limited
Forward Citations = 1
11 inventors:
Reviral Limited
% Expired Patents = 60.0
EPO Patents = 4
Forward Citations = 1
Loading Chart...
Loading Chart...
11 inventors (with patents filed for the assignee):
Stuart George Cockerill (4 out of 5 patents)
James Good (2 out of 6 patents)
Neil Mathews (2 out of 6 patents)
4. Simon Ward (1 out of 5 patents)
5. Matthew Barrett (1 out of 3 patents)
6. Graham Lunn (1 out of 1 patent)
7. Michael Paradowski (1 out of 1 patent)
8. Jose Miguel Gascon Simorte (1 out of 1 patent)
9. Christopher Pilkington (1 out of 2 patents)
10. James Lumley (1 out of 3 patents)
11. Richard Angell (1 out of 13 patents)
5 patents:
Company Overview
Reviral Limited is a leading biotechnology company focused on developing innovative antiviral therapies. Our team of experts is dedicated to creating therapies that target a broad range of viral infections, with a focus on respiratory viruses. With a commitment to improving global health, we are driven to deliver cutting-edge solutions for unmet medical needs.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Reviral Limited. Retrieved from https://idiyas.com/company/reviral
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]